跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOTAGRAF gadoteric acid 2.79 g/10 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DOTAGRAF gadoteric acid 2.79 g/10 mL solution for injection vial
Approved
STANDARD
DOTAGRAF gadoteric acid 2.79 g/10 mL solution for injection vial
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
cb9a8ff43c3f822b
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
cb9a8ff43c3f822b
Product Name
DOTAGRAF gadoteric acid 2.79 g/10 mL solution for injection vial
Artg Id
351770
Artg Name
DOTAGRAF gadoteric acid 2.79 g/10 mL solution for injection vial
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2022-10-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3748e8d183e4ff6f7d718946fe8eeb3b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/69d222045149e245903890846533b88a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
cb9a8ff43c3f822b
Type
Standard
Back to TGA Approvals